Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goepfert

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
Journal of the National Cancer Institute|April 17, 1996
p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinomaD M Shin, J S Lee, S M Lippman, et al.
The Laryngoscope|December 1, 1980
Anti-EBV serologic tests for nasopharyngeal carcinomaH B Neel, G R Pearson, L H Weiland, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1983
Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinomaH B Neel, G R Pearson, L H Weiland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Cancer|January 15, 1983
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinomaG R Pearson, L H Weiland, H B Neel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
Cancer Detection and Prevention|January 1, 1981
The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC)P H Levine, G R Pearson, M Armstrong, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Head and Neck CancersD G Pfister, K Ang, B Brockstein, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Journal of the National Cancer Institute|April 17, 1996
p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinomaD M Shin, J S Lee, S M Lippman, et al.
The Laryngoscope|December 1, 1980
Anti-EBV serologic tests for nasopharyngeal carcinomaH B Neel, G R Pearson, L H Weiland, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1983
Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinomaH B Neel, G R Pearson, L H Weiland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Cancer|January 15, 1983
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinomaG R Pearson, L H Weiland, H B Neel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
Cancer Detection and Prevention|January 1, 1981
The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC)P H Levine, G R Pearson, M Armstrong, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Head and Neck CancersD G Pfister, K Ang, B Brockstein, et al.
Pageof 25